BTN3A2 Protein (AA 30-248) (His-Avi Tag)
Quick Overview for BTN3A2 Protein (AA 30-248) (His-Avi Tag) (ABIN7273980)
Target
See all BTN3A2 ProteinsProtein Type
Biological Activity
Origin
Source
Purity
-
-
Protein Characteristics
- AA 30-248
-
Purification tag / Conjugate
- This BTN3A2 protein is labelled with His-Avi Tag.
-
Purpose
- Non-biotinylated Human BTN3A2 Protein
-
Sequence
- Gln30-Trp248
-
Characteristics
- Recombinant Human BTN3A2 Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Gln30-Trp248.
-
Sterility
- 0.22 μm filtered
-
Endotoxin Level
- Less than 1 EU per μg by the LAL method.
-
Biological Activity Comment
- Human BTN3A2 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.,The purity of Human BTN3A2 is greater than 95% as determined by SEC-HPLC.
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Dissolve the lyophilized protein in distilled water. It is recommended to resuspend at 0.5 mg/mL if the lyophilized powder is 100 μg or less, at 1 mg/mL for 500 μg or 1 mg lyophilized powder. Do not mix by vortex or vigorous shaking.
-
Buffer
- Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- -20 to -80°C for 12 months as supplied from date of receipt.,-80°C for 3 months after reconstitution.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- BTN3A2 (Butyrophilin, Subfamily 3, Member A2 (BTN3A2))
-
Alternative Name
- BTN3A2
-
Background
- BTN3A2/BT3.2 butyrophilin mRNA expression by tumoral cells was previously identified as a prognostic factor in a small cohort of high grade serous epithelial ovarian cancer (HG-EOC).In conclusion, BT3.2 protein is a potential prognostic biomarker for the identification of HG-EOC patients with better outcome. In contrast, high CD206 /CD68 expression is associated with high risk of disease progression.
-
Molecular Weight
- 26.5 kDa. Due to glycosylation, the protein migrates to 27-33 kDa based on Bis-Tris PAGE result.
-
UniProt
- P78410
Target
-